Evidence map›Paper›PMID 32493482›Full record

ArticleBMC pharmacology & toxicology2020

18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.

Jintao Gao, Junfan Guo, Yuejuan Nong, Wenfei Mo, Huanan Fang, Jing Mi, Qi Qi, Mengjuan Yang

Open access · goldAbstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Etanercept ameliorates psoriasis progression through regulating high mobility group box 1 pathway.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023
    Article
  7. Review
  8. Article
  9. AIM2 and Psoriasis.Frontiers in immunology · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Life (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jintao GaoCollege of Biotechnology, Guilin Medical University, Guilin, 541100, Guangxi, People's Republic of China. jintao_gao@glmc.edu.cn.ORCID 0000-0002-3991-9706
Junfan GuoCollege of Biotechnology, Guilin Medical University, Guilin, 541100, Guangxi, People's Republic of China.
Yuejuan NongCollege of Biotechnology, Guilin Medical University, Guilin, 541100, Guangxi, People's Republic of China.
Wenfei MoCollege of Biotechnology, Guilin Medical University, Guilin, 541100, Guangxi, People's Republic of China.
Huanan FangCollege of Biotechnology, Guilin Medical University, Guilin, 541100, Guangxi, People's Republic of China.
Jing MiCollege of Biotechnology, Guilin Medical University, Guilin, 541100, Guangxi, People's Republic of China.
Qi QiCollege of Biotechnology, Guilin Medical University, Guilin, 541100, Guangxi, People's Republic of China.
Mengjuan YangCollege of Biotechnology, Guilin Medical University, Guilin, 541100, Guangxi, People's Republic of China.
Guilin Medical University · CN

Funding

National Nature Science Foundation of China 31860314Natural Science Foundation of Guangxi Zhuang Autonomous Region 2016GXNSFBA380146Natural Science Foundation of Guangxi Zhuang Autonomous Region 2018GXNSFAA281041
6 · The paper itself

Abstract

backgroundPsoriasis is a chronic inflammatory skin disease affecting 2-3% of the population worldwide. Hyperproliferative keratinocytes were thought to be an amplifier of inflammatory response, thereby sustaining persistence of psoriasis lesions. Agents with the ability to inhibit keratinocyte proliferation or induce apoptosis are potentially useful for psoriasis treatment. 18β-Glycyrrhetinic acid (GA), an active metabolite of glycyrrhizin, exhibits diverse pharmacological activities, including anti-inflammatory, anti-bacteria and anti-proliferation. The current study aims to evaluate the effects of GA on the proliferation and apoptosis of human HaCaT keratinocytes in vitro and investigate the effects of GA on the skin lesions of imiquimod (IMQ)-induced psoriasis-like mouse model in vivo.

methodsCell viability was assayed by CCK-8. Flow cytometry was performed to measure apoptosis and reactive oxygen species (ROS), with Annexin V-FITC/PI detection kit and DCFH-DA probe respectively. Caspase 9/3 activities were measured using caspase activity assay kits. The protein levels of Akt and p-Akt were determined using Western blotting. IMQ was applied to induce psoriasis-like skin lesions in mice. The histological change in mouse skin lesions was detected using hematoxylin and eosin (H&E) staining. The severity of skin lesions was scored based on Psoriasis Area Severity Index (PASI). RT-PCR was employed to examine the relative expression of TNF-α, IL-22 and IL-17A in mouse skin lesions.

resultsGA decreased HaCaT keratinocytes viability and induced cell apoptosis in a dose-dependent manner. In the presence of GA, intracellular ROS levels were significantly elevated. NAC, a ROS inhibitor, attenuated GA-mediated HaCaT keratinocytes growth inhibition and apoptosis. In addition, GA treatment remarkably decreased p-Akt protein level, which could be restored partially when cells were co-treated with GA and NAC. LY294002 (a PI3K inhibitor) treatment significantly enhanced GA-mediated cytotoxicity. Moreover, GA ameliorated IMQ-induced psoriasis-like skin lesions in mice.

conclusionsGA inhibits proliferation and induces apoptosis in HaCaT keratinocytes through ROS-mediated inhibition of PI3K-Akt signaling pathway, and ameliorates IMQ-induced psoriasis-like skin lesions in mice.

Indexed as

AnimalsApoptosisCell LineCytokinesFemaleGlycyrrhetinic AcidHumansImiquimodKeratinocytesMice, Inbred C57BLPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPsoriasisReactive Oxygen SpeciesSignal TransductionSkin18alpha-glycyrrhetinic acidCytokinesGlycyrrhetinic AcidImiquimodPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen Species18β-Glycyrrhetinic acidApoptosisPI3K-Akt signaling pathwayPsoriasisROS

Identifiers

PMID32493482
PMCPMC7271483
OpenAlexW3029499414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.